Notable
in vivo CAR-T · TI-0032-III Injection · Relapsed and Refractory Autoimmune Diseases
Primary completion pushed from May 1, 2026 to May 1, 2027
Also in this update: Study completion pushed from Jan 30, 2027 to May 30, 2027
TherornaPhase 1 NCT07413341 Registry history of NCT07413341 on ClinicalTrials.gov (opens the registry)